Doctors Appeal Ruling in Favor of FDA Over Ivermectin Posts, Urge Court to Intervene

Dr. Paul Marik, co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC) and former chief of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School, at the FLCCC conference "Understanding & Treating Spike Protein-Induced Diseases" in Kissimmee, Fla. on Oct. 14, 2022. The Epoch Times

A group of doctors is urging a U.S. court to block the Food and Drug Administration (FDA) from issuing guidance on using ivermectin, in an appeal lodged after a district court judge rejected their bid.

The FDA “cannot advise whether or for what purpose a doctor should prescribe, or a patient should take, an approved drug,” lawyers for Drs. Paul Marik, Mary Talley Bowden, and Robert Apter said in a February brief to the U.S. Court of Appeals for the Fifth Circuit.